Desktop notifications are on | Turn off
Get breaking news alerts from The Washington Post
Turn on desktop notifications?
Updated Feb 12, 2021 at 11:39 AM EST
The pharmaceutical giant said in its quarterly SEC filing in October, 2020 it expects to pay a total of $5 billion into the nationwide opioid settlement. The company said it expects this amount to be taxed at an effective rate of 21.4 percent, suggesting it expects to deduct roughly $1.1 billion of those costs. In the same footnote, Johnson & Johnson says changes in regulations could alter the amount of the settlement it ultimately is able to deduct.
Click here to download if the document isn't visible or legible.
Johnson & Johnson disclosed plans in an SEC filing to take a tax deduction to offset costs from the company's opioid litigation settlement.
Please enter a valid email address.
Already a subscriber? Sign inBy submitting your email, you agree to our Terms of Service and Privacy Policy.
You’re all set!
We sent this offer to john.smith@gmail.com